The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change sought by the pharmaceutical industry.

President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price negotiations in Medicare, a fix that could address one of the drug industry’s top complaints with the Biden-era law.

Billionaire entrepreneur Mark Cuban backed President Donald Trump's executive order on prescription drugs and healthcare and offered his insights on reforms in the pharmaceutical industry.